Strategy & Performance
Strategic Support for FilaTech Group's Generational Transition
H&Z supported PREMIUM Equity Partners in FilaTech Group's generational change conducting the commercial due diligence.
Client Challenge
The client faced several challenges:
- Limited transparency given the niche nature of the addressable markets for spinning systems
- Gaining confidence on substitution threaths of GLP-1 pharmaceuticals for dyalisis treatment
- Identifying potential new market segments to validate upsides
H&Z Approach
H&Z leveraged their expertise to quickly and deeply understand a niche and undocumented market. Working closely with the customer (PE firm) and through an extensive primary research program, the team enriched the existing investment hypotheses with market analytics and storytelling. In the second phase, H&Z focused on validating and quantifying the potential upsides in new applications and markets for FilaTech.
Results
Alongside the families and new CEO Robert de Deugd, PREMIUM will support on growth opportunities and an impressive project pipeline. The firm aims to advance geographical diversification and broaden the product range into technical applications, including gas and water membranes.
If you would like to find out more about how we help clients, please get in touch with our dedicated M&A Advisory team.
Markus Contzen
